Eurofins ramps up its multi-million laboratory network upgrade in Australia and New Zealand

Eurofins Scientific (EUFI.PA), the global leader in food and environment testing, announces the acceleration of its modernisation and expansion program to bring its laboratories across Australia and New Zealand to world-class standards, and provide its clients in the region the same standards and capabilities that have come to define Eurofins in other parts of the world. The ca. AUD 15m (ca. EUR 10m) investment programme, which commenced in January 2013 includes the extensive upgrade of 7,300m²  of laboratory surface in the Group's 7 laboratories and 12 agroscience sites in the region, the construction of a brand new 600m² laboratory Christchurch, NZ, in addition to the new state-of-the-art quarantine facility in Toowoomba, QLD, announced in September. 

The comprehensive upgrade of 3,600m² laboratory surface in Sydney and Melbourne closely follows the completion of the 3,700m² extensive rebuild of Eurofins' main site in Auckland, New Zealand earlier this year. The modernisation program will continue in 2015 with the construction of a brand new 600m² site in Rolleston Christchurch, further underscoring the Group's commitment to the Food and Dairy segments in the South Island of New Zealand. The new facility is expected to be completed in April 2015.

Eurofins also brought together its Rozelle and Orange sites into a new, large facility in Lane Cove, to consolidate its competencies in agrochemical and veterinary medicine GLP studies, as well as routine pesticide and herbicide analysis. In addition, Eurofins has established three competence centers for the analyses of Asbestos (Sydney), SPOCAS (Brisbane) and AFF-PFOS (Brisbane), all of which are NATA-accredited.

The modernised laboratories boast state-of-the-art equipment and instrumentation, consistent with the Group's laboratories in Europe and the US, designed for optimal efficiency, allowing Eurofins to continue to deliver the highest-quality of analytical services at industry-beating turnaround times (TAT).

Comment fromDr. Matthias-Wilbur Weber, Eurofins Group Executive Vice President for Asia Pacific: "The investments Eurofins has poured into our laboratories in Australia and New Zealand is a further demonstration of our plans to accelerate our network build-up in the overall region, and reflects our commitment to further strengthen our Asia Pacific footprint. We intend to continue to extend the full capabilities of the Eurofins Group to benefit our clients in Asia Pacific, and look forward to becoming the laboratory partner of choice for the food and environmental industries in the region".

For more information please contact:

Notes for the editor:

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.

With over 16,000 staff in more than 200 laboratories across 36 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results in time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.